JW Pharmaceutical Corporation

KRX:001060.KS

28550 (KRW) • At close October 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income 35,096.02829,852.56-1,441.453-15,275.471-25,275.0168,056.889-742.474-10,933.5441,961.4271,446.8772,274.88-20,393.601-9,803.5965,600.27210,918.7186,433.1788,761.048
Depreciation & Amortization 22,444.59816,836.3216,111.74720,688.16520,349.05417,682.29618,789.40418,645.78417,863.12616,616.95716,153.13814,358.53412,839.7299,037.72610,429.95412,454.13712,649.332
Deferred Income Tax 00000000000000000
Stock Based Compensation 00000000000000000
Change In Working Capital -20,262.513-6,169.67-46,055.7835,217.30162,912.458-393.621-15,515.89-14,565.929-37,919.731-19,853.949-5,773.7953,254.314-31,111.635-44,929.689-53,964.118-41,256.118-29,804.607
Accounts Receivables -3,162.23-4,352.537-41,296.6445,698.51538,275.32628,911.027-227.573-10,013.128-25,059.03900000000
Inventory 8,916.798-11,541.331-2,655.11-8,876.46919,783.53-5,784.077-11,120.786-16,671.519-11,970.4024,258.716-5,513.52816,310.7084,250.477,838.692-22,224.164-21,244.43-9,480.929
Accounts Payables -9,535.56231,652.2963,729.6772,831.144-632.933-15,169.481299.7423,062.4932,330.41700000000
Other Working Capital -16,481.519-21,928.098-5,833.707-4,435.8895,486.5355,390.456-4,395.1042,105.59-25,949.329-24,112.665-260.26236,943.606-35,362.105-52,768.381-31,739.954-20,011.688-20,323.678
Other Non Cash Items 49,879.12316,245.22849,509.46922,424.371-2,455.41126,764.36930,919.13213,592.32513,920.2489,069.2136,070.27616,995.5359,891.76418,612.52521,496.68821,020.80623,212.876
Operating Cash Flow 87,157.23656,764.43918,123.98263,054.36755,531.08552,109.93333,450.1726,738.636-4,174.937,279.09818,724.50464,214.782-18,183.738-11,679.166-11,118.758-1,347.99714,818.649
Investing Activities:
Investments In Property Plant And Equipment -42,967.19-12,352.501-12,901.583-15,039.061-13,096.432-8,345.043-10,950.92-10,021.425-9,112.334-12,021.717-10,567.378-20,099.958-21,077.16-39,448.367-68,231.926-37,745.445-15,830.385
Acquisitions Net -12,033.989-40.884384.964-5,625-5,349.145-5,178.8631.389-1,616.1213,555.89118,243.203-6,249.532-1,966.968-9,916.854-9,009.253-2,003.551-3,064.511-1,000
Purchases Of Investments -61,344.003-73,817.4-140,023.467-56,346.636-15,470.959644.401-214.488-58,045-660-2,510-30-162-226-22,651.048-600-2,336.573-93,521.546
Sales Maturities Of Investments 69,604.0347,473.709141,101.74316.64112,0001402060,151.98760.7271,398.397385.531272.192673.38331,363.3482,458.461,683.98991,776.392
Other Investing Activites -17,093.11819,817.917-11,430.809-2,433.237-67.196-1,178.8651,040.005760.695-1,890.9265,712.7666,284.8952,140.65311,338.9479,816.495,051.6024,223.964-597.257
Investing Cash Flow -63,834.27-18,919.16-22,869.152-79,427.292-21,983.732-13,918.367-9,890.915-8,769.871-7,346.64210,822.648-10,176.483-19,816.082-19,207.685-29,928.83-63,325.415-37,238.576-19,172.796
Financing Activities:
Debt Repayment -28,189.8-177,004.403-98,658.134-169,308.252-158,874.769-200,136.498-197,214.168-186,629.687-154,903.239-173,303.186-149,047.166-104,907.04-489,629.143-382,757.818-70,000-20,000-520,300.263
Common Stock Issued -3,872.9829,999.993398.4710166,765.377184,829.105466.012224,077.3258,299.9285,899.9889,999.99712,975.0211,852.44424,555.75600528,600
Common Stock Repurchased -260.875-281.6-412.292-224.245-258.458-9,370.637-317.286-218.636-37.655-42.755-40.107-44.282-46.267-60.200-2,102.936
Dividends Paid -8,813.671-7,351.968-7,149.5-6,953.837-6,815.539-5,820.291-5,884.381-2,711.662-2,694.37-1,752.506-1,449.578-2,043.504-2,940.681-2,856.067-2,767.247-2,686.742-2,974.423
Other Financing Activities -54137,730.523133,023.045162,476.93-24,976.894-10,000.193175,075.185-691.891164,011.346155,129.624130,578.86950,000521,404.290.001144,470.66760,504-250.537
Financing Cash Flow -41,191.329-36,907.45427,201.59-14,009.405-24,160.283-41,188.514-27,874.63833,825.44914,676.009-14,068.836-9,957.985-44,019.80430,640.6438,881.67271,703.4237,817.2582,971.841
Other Information:
Effect Of Forex Changes On Cash -120.694-406.377458.716-1,030.581,528.7621,848.534-2,841.57-723.99457.188-13.032-21.667-52.123-4.864000-1,007.269
Net Change In Cash -17,989.057531.44822,915.136-31,412.9110,915.831-1,148.415-7,156.95131,070.2193,211.6254,019.877-1,431.631326.773-6,755.647-2,726.324-2,740.753-769.315-2,389.575
Cash At End Of Period 15,908.86833,897.92533,366.47710,451.34141,864.25230,948.4232,096.83539,253.7868,183.5674,971.941952.0642,383.6942,056.9228,636.02711,362.35114,103.10414,872.419